As expected, Cellular Dynamics International announces yet another licensing agreement for iPS cell technology.
A review of recent, and not-so-recent, advances in stem cell science reveal that any clinical applications of embryonic stem cell research are still decades away.
The new Guidelines issued by NIH are seen by many embryonic stem cell scientists as an obstacle to research.
Autologous adult stem cell therapies that are routinely used for the treatment of injuries and degenerative conditions in dogs and horses are now being translated into human clinical trials.
The embryonic stem cell company BioTime receives $4 million in its second equity tranche.
There were approximately 49,000 comments sent into the NIH in response to a publicly available draft of the new guidelines to embryonic stem cell research.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.